Archive · 22 Jan 2026
SCTIMST Develops Tissue Graft for Faster Wound Healing
Scientists in India have created a special tissue graft called Cholederm from the gall bladders of farm animals.
This graft helps wounds heal faster with less scarring.
The product, developed by SCTIMST, has been approved by health authorities and is being produced by a company called Alicorn Medical.
Doctors have used it to treat patients with long-lasting ulcers, and it has worked well.
The technology also helps farmers by turning something usually thrown away into something useful.
The scientists and the company are working to make sure this product meets high standards and can be used all over the world.
SCTIMST developed Cholederm, a tissue graft from farm animal gall bladders, to accelerate wound healing.
The product is approved by the Central Drugs Standards Control Organisation and is being commercially produced by Alicorn Medical.
Cholederm promotes faster healing with minimal scarring and has been successfully used on over 20 patients.
The technology converts slaughterhouse waste into a high-value byproduct, benefiting livestock farmers.
SCTIMST and Alicorn Medical are pursuing international regulatory approvals to ensure global accessibility.
- Who
- Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) and Alicorn Medical Pvt Ltd
- What
- Developed Cholederm, a tissue graft scaffold for wound healing
- When
- Technology developed since 2008, commercial production initiated in 2017, approved in 2023
- Where
- Thiruvananthapuram, India
- Why
- To accelerate wound healing, reduce scarring, and convert slaughterhouse waste into a high-value byproduct
- Institute
- Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)
- Product Name
- Cholederm (CholeDermR)
- Source Material
- Gall bladder of farm animals
- Approval
- Central Drugs Standards Control Organisation (2023)
- Commercial Partner
- Alicorn Medical Pvt Ltd
- Patents
- 10 Indian patents
- Research Duration
- Since 2008
- Clinical Trials
- Over 20 patients treated successfully